Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Report ID | 165092 |
Drug Identification Number | 02458608 |
Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
Common or Proper name | NAPROXEN/ESOMEPRAZOLE MR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
Strength(s) | 20MG 375MG |
Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 BT |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-11 |
Estimated end date | 2022-09-06 |
Actual end date | 2022-09-06 |
Shortage status | Resolved |
Updated date | 2022-09-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2022-09-07 | French | Compare |
v13 | 2022-09-07 | English | Compare |
v12 | 2022-09-07 | French | Compare |
v11 | 2022-09-07 | English | Compare |
v10 | 2022-08-23 | French | Compare |
v9 | 2022-08-23 | English | Compare |
v8 | 2022-08-15 | French | Compare |
v7 | 2022-08-15 | English | Compare |
v6 | 2022-08-04 | French | Compare |
v5 | 2022-08-04 | English | Compare |
v4 | 2022-08-03 | French | Compare |
v3 | 2022-08-03 | English | Compare |
v2 | 2022-07-20 | French | Compare |
v1 | 2022-07-20 | English | Compare |
Showing 1 to 14 of 14